Compositions and Methods for Treating the Eye

US2021145909A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021145909-A1
Application numberUS-202017099185-A
CountryUS
Kind codeA1
Filing dateNov 16, 2020
Priority dateNov 19, 2019
Publication dateMay 20, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid and/or mucin from and/or in the cornea, and methods of using the compositions to treat the eye.

First claim

Opening claim text (preview).

What is claimed is: 1 . A microemulsion composition for treating the eye comprising: i) one or more extracts, or sources of extracts, of the genus Pichia ; and ii) an ophthalmologically acceptable carrier wherein the microemulsion droplets or particles have a maximum dimension of less than 1,500 Å. 2 . The composition according to claim 1 , wherein the genus of Pichia is selected from Pichia anomala, Pichia guilhermondii, Pichia norvegensis, Pichia ohmeri and mixtures thereof. 3 . The composition according to claim 2 , wherein the genus of Pichia is Pichia anomala. 4 . The composition of claim 1 , where in the one or more extracts, or sources of extracts, of the genus Pichia are present at a concentration of from about 0.001% to about 100% by weight of the total composition. 5 . The composition of claim 1 , where in the one or more extracts, or sources of extracts, of the genus Pichia are present at a concentration of from about 0.005% to about 95% by weight of the total composition. 6 . The composition of claim 1 , where in the one or more extracts, or sources of extracts, of the genus Pichia are present at a concentration of from about 0.01% to about 90% by weight of the total composition. 7 . The composition according to claim 1 , comprising a permeation enhancer. 8 . The composition of claim 7 wherein the permeation enhancer is present at a concentration of from about 0.01% to about 20% (w/v) of the total composition. 9 . The composition of claim 8 wherein the permeation enhancer is present at a concentration of from about 0.1% to 10% (w/v) of the total composition. 10 . The composition of claim 9 wherein the permeation enhancer is present at a concentration of from about 0.25% to 5% (w/v) of the total composition, 11 . The composition of claim 7 wherein the permeation enhancer is selected from polyoxyethylene, polyoxyethylene ethers of fatty acids, sorbitan monooleate, sorbitan monolaurate, polyoxyethylene monolaurate, polyoxyethylene sorbitan monolaurate, fusidic acid and derivatives thereof, EDTA, disodium EDTA, cholic acid, deoxycholic acid, glycocholic acid, glycodeoxycholic acid, taurocholic acid, taurodeoxycholic acid, sodium cholate, sodium glycocholate, glycocholate, sodium deoxycholate, sodium taurocholate, sodium glycodeoxycholate, sodium taurodeoxycholate, chenodeoxycholic acid, urosdeoxycholic acid, saponins, glycyrrhizic acid, ammonium glycyrrhizide, decamethonium, decamethonium bromide, and dodecyltrimethylammonium bromide or mixtures of any of the above. 12 . The composition of claim 1 wherein the Pichia genus extract comprises oligosaccharides and polysaccharide having a weight average molecular weight of from about 180 to about 800,000 Da. 13 . The composition of claim 1 wherein the Pichia genus extract comprises oligosaccharides and polysaccharide having an average degree of polymerization of from DP 1 to DP 4444.

Assignees

Inventors

Classifications

  • A61K36/064Primary

    Saccharomycetales, e.g. baker's yeast · CPC title

  • Inorganic compounds · CPC title

  • Carboxylic acids; Salts or anhydrides thereof · CPC title

  • Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title

  • Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021145909A1 cover?
The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid and/or mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
Who is the assignee on this patent?
Johnson & Johnson Consumer Inc
What technology area does this patent fall under?
Primary CPC classification A61K36/064. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu May 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).